Adjuvant chemoradiotherapy for stage III gastric cancer: A differential role in R0 and non-R0 resection
Adjuvant CCRT was associated with a trend toward improved survival in patients with non-R0 resection. However, it was not associated with additional survival benefits compared with chemotherapy in patients undergoing R0 resection after D2 lymphadenectomy, indicating that systemic therapy alone may be sufficient. These findings support the selective use of CCRT and underscore the need for prospective studies to optimize adjuvant strategies.
Authors
- Nai-Jung Chiang (ORCID: https://orcid.org/0000-0001-9292-0055)
- Ching-Yun Kung
- Hung-Yuan Yu (ORCID: https://orcid.org/0000-0001-7170-3502)
- Y. F. Chao
- Yin-Che Wang
- Ming Huang Chen
- I-Hsiang Lai
- Ky Huang
- Yi-Ping Hung
- Anna Fen-Yau Li
- Wen-Liang Fang
- Shih-Chieh Lin
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Cheng Hsin General Hospital (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1097/jcma.0000000000001332
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52